You can buy or sell uniQure and other stocks, options, ETFs, and crypto commission-free!
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. Read More The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.
52 Week High
52 Week Low
— per share
Expected Jul 27, Pre-Market